Search

everythinglearnresearchcommunity

for

Search:↓

Stopping the medication infliximab and starting new treatments helped a woman's hair grow back and improved her scalp condition.

Long-term Imiquimod treatment causes initial skin inflammation that lessens over time, and topical corticosteroids reduce this inflammation and cytokines in a mouse model of psoriasis.

Ruxolitinib can help regrow hair in severe alopecia areata.

Clq deficiency is linked to systemic lupus erythematosus symptoms.

The FDA approved a new Pfizer drug for hair loss in teens.

Oral isotretinoin, especially at higher doses for at least 3 months, is effective for treating folliculitis decalvans.

FCER1A and RGS1 may help diagnose and treat systemic lupus erythematosus.

RNase L hinders hair growth by altering immune signals.

The new nasal gel for schizophrenia improved drug absorption and brain effects in rats.

An antibiotic called co-trimoxazole can effectively treat autoimmune diseases.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Leflunomide and anthralin may effectively treat severe alopecia areata.

RHA fillers are effective and safe for treating nasolabial folds in people of color.

The combination therapy effectively treats infertility in PCOS without major side effects.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

Collaborative care between physicians and pharmacists improved medication management for rheumatoid arthritis without raising costs.

Ruxolitinib helps regrow hair in alopecia areata by blocking inflammation, reducing stress, and controlling cell death.

Acne patients have higher skin mTORC1 activity, which is reduced by isotretinoin treatment.

Pediatric systemic lupus erythematosus is a severe autoimmune disease in children requiring early diagnosis and comprehensive management.

Apremilast did not work for treating severe alopecia areata.

Tofacitinib may help regrow hair in alopecia areata patients.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

The document did not conclude on apremilast's effectiveness for severe alopecia areata.

GLP-1 receptor agonists can cause skin reactions, facial fat loss, and hair loss, but may help with wound healing and skin conditions.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

RNase L suppresses regeneration in mammals.

PRF lysates reduce inflammation in cancer cells and boost immune response in healthy oral cells.

The effect of GLP-1 RAs on erectile function is unclear and needs more research.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Tofacitinib may be an effective and safe treatment for adolescent alopecia areata.